Cooperative Agreement U48DP006938
Award Date 9/30/25
Completion Date 9/30/29
Dollars Obligated $350K
Funding Federal Agency
Awarding Federal Agency
Federal Grant Program
Assistance Type
Cooperative Agreement
Place of Performance
Minneapolis, MN, USA
Similar Awards
- This $350,000 Cooperative Agreement award was provided by the Centers for Disease Control and Prevention's National Center for Injury Prevention and Control under the Injury Prevention and Control Research and State and Community Based Programs (CFDA 93.136) on September 30, 2025. The award will support research and coordination to expand access to Medications for Opioid Use Disorder (MOUD) for patients in emergency departments over a 4-year period through September 29, 2029. The University of...
- This Cooperative Agreement award for $348,837 was granted by the Centers for Disease Control and Prevention's National Center for Injury Prevention and Control under the Injury Prevention and Control Research and State and Community Based Programs (CFDA 93.136). The award supports research by The General Hospital Corporation (Massachusetts General Hospital) on the effects of high-dose medications for opioid use disorder on treatment retention, drug use patterns, and overdose risks amidst the...
- The Centers for Disease Control and Prevention (CDC) awarded a $350,000 Cooperative Agreement under the Injury Prevention and Control Research and State and Community Based Programs (CFDA 93.136) to King County, doing business as Public Health-Seattle & King County, to conduct a rigorous evaluation of community-delivered short- and long-acting buprenorphine treatments for people experiencing homelessness or living in permanent supportive housing. The award, effective September 30, 2025,...
- The U.S. Centers for Disease Control and Prevention (CDC), through the Injury Prevention and Control Research and State and Community Based Programs (CFDA 93.136), awarded a $449,998 Cooperative Agreement to the University of Pennsylvania to support the "PRAGMATIC IMPLEMENTATION OF STRATEGIC INTERVENTIONS TO IMPROVE INITIATION OF MOUD WITHIN EMERGENCY DEPARTMENTS." The project aims to develop and implement effective practices for preventing injuries and violence, with a focus on...
- This federal Cooperative Agreement award of $680,100 from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), is intended to investigate the use of a combined transcranial direct current stimulation (tDCS) and cognitive training intervention as an adjunct treatment for individuals with opioid use disorder (OUD) who are receiving buprenorphine maintenance treatment. The key products and services to be delivered under this award include:...
- This federal Cooperative Agreement award, titled "ENHANCING PROJECT DHARMA; EVALUATING A COMMUNITY-BASED DRUG CHECKING NAVIGATOR INTERVENTION TO PREVENT OVERDOSES", is funded by the Centers for Disease Control and Prevention's Injury Prevention and Control Research and State and Community Based Programs (CFDA 93.136). The $700,000 award, granted on Sep 30, 2025, supports Mainehealth, a non-profit healthcare system based in Portland, Maine, in developing and evaluating a community-based...
- The federal Cooperative Agreement award CE25-149, "ENGAGING OVERDOSE SURVIVORS WITH THE SAFESPOT HOTLINE FOR SECONDARY OVERDOSE PREVENTION", is funded by the Centers for Disease Control and Prevention's (CDC) Injury Prevention and Control Research and State and Community Based Programs (CFDA 93.136). The $698,150 award, granted to the Boston Medical Center Corporation (BMC), aims to develop and implement an intervention that engages overdose survivors with the SafeSpot hotline for...
- This Cooperative Agreement award from the Centers for Disease Control and Prevention's Injury Prevention and Control Research and State and Community Based Programs (CFDA 93.136) provides $699,911 in funding to The Johns Hopkins University to conduct a Randomized Clinical Trial of a Peer Education Intervention to Promote Social Diffusion of Overdose Prevention and Drug Use Cessation in High Burden Communities. The project period is from Sep 30, 2025 to Sep 29, 2030. The goal of the research is...
- This Cooperative Agreement award, CE25-149, was provided by the Centers for Disease Control and Prevention's (CDC) Injury Prevention and Control Research and State and Community Based Programs (CFDA 93.136). The $349,258 grant was awarded to the University of North Carolina at Chapel Hill (UNC-CH) on September 30, 2025 for a project period ending on September 29, 2028. The grant will fund research on the effect of Medicaid expansion on medications for opioid use disorder, mental health care, and...
- This Project Grant award of $1,600,000 from the U.S. Department of Justice's Bureau of Justice Assistance under the Comprehensive Opioid, Stimulant, and Substance Use Program (CFDA 16.838) will support Hennepin County, Minnesota in three key objectives: Increase access to opioid use disorder (OUD) treatment for detained individuals, particularly those who are disproportionately African American and Native American, by hiring a dedicated sheriff's deputy to transport and escort detainees to...